NEAT1 and prostate carcinoma: Studies found that high m6A level of NEAT1–1 was correlated with bone metastasis of prostate cancer as well as m6A level of NEAT1–1 may be new target for diagnosis and therapy of bone metastatic prostate cancer (Wen et al., 2020).